Start | Browse by Day | Author Index

50E Hypoglycemia and costs in patients newly initiated on exenatide or insulin glargine

Sunday, April 26, 2009
Rolin Wade, RPh, MS , HealthCore, Inc., Wilmington, DE
Loretta Nielsen, PhD , Amylin Pharmaceuticals, Inc., San Diego, CA
Rosalind Fabunmi, PhD , Amylin Pharmaceuticals, Inc., San Diego, CA
Ralph Quimbo, MA , HealthCore, Inc., Wilmington, DE
Brock Schroeder, PhD , Amylin Pharmaceuticals, Inc., San Diego, CA
Marjan Massoudi, PharmD , Amylin Pharmaceuticals, Inc., San Diego, CA
Derek Misurski, PhD , Eli Lilly and Company, Indianapolis, IN
Matthew Wintle, MD , Amylin Pharmaceuticals, Inc., San Diego, CA
See more of: Scientific Poster Presentation II
See more of: Original Research
<< Previous Abstract | Next Abstract >>